Drugs aren’t the foundation of a healthy society. Your editorial raises a valid concern: equitable access to weight-loss drugs like Wegovy. However, while affordability matters, ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...